COMMUNIQUÉ DE PRESSE publié le 19/03/2026 à 07:00, il y a 1 mois 21 jours DocMorris and Google partner to advance one of Europe’s leading AI-powered digital health platform DocMorris and Google partner to advance digital health platform with AI technology, enhancing patient services. Google's AI capabilities and secure cloud infrastructure utilized for innovative healthcare solutions AI Technology Partnership Google DocMorris Digital Health Platform
COMMUNIQUÉ DE PRESSE publié le 19/03/2026 à 06:58, il y a 1 mois 21 jours DocMorris achieves 2025 targets – focus on profitability, growth and expansion of digital health platform DocMorris AG achieves 2025 targets with focus on profitability, growth, and digital health platform expansion. Partnership with Google boosts AI strategy. Ludwigshafen site closure for efficiency Profitability Growth DocMorris AG 2025 Targets Digital Health Platform
BRÈVE publiée le 03/03/2026 à 07:05, il y a 2 mois 6 jours DocMorris AG annonce des changements au sein de son conseil d'administration Stratégie D'entreprise Assemblée Générale Annuelle DocMorris AG Changements Au Conseil D'administration Nouvelles Nominations
BRÈVE publiée le 03/03/2026 à 07:05, il y a 2 mois 6 jours DocMorris AG Announces Changes to Its Board of Directors Annual General Meeting New Appointments Board Changes Corporate Strategy DocMorris AG
COMMUNIQUÉ DE PRESSE publié le 03/03/2026 à 07:00, il y a 2 mois 6 jours DocMorris AG announces changes to its Board of Directors DocMorris AG announces changes to its Board of Directors, with Prof. Stefan Feuerstein, Dr Christian Mielsch, and Rongrong Hu not standing for re-election, proposing the election of new members at the upcoming Annual General Meeting Board Of Directors Annual General Meeting Personnel Changes DocMorris AG New Members
BRÈVE publiée le 02/02/2026 à 17:50, il y a 3 mois 6 jours DocMorris annonce le remboursement anticipé d'obligations convertibles à 6,875 % Obligations Convertibles Finance DocMorris Conversion D'obligations Rachat Anticipé
BRÈVE publiée le 02/02/2026 à 17:50, il y a 3 mois 6 jours DocMorris Announces Early Redemption of 6.875% Convertible Bonds Convertible Bonds Finance Early Redemption DocMorris Bond Conversion
COMMUNIQUÉ DE PRESSE publié le 02/02/2026 à 17:45, il y a 3 mois 6 jours Early redemption of the 6.875% Convertible Bonds due 2026 DocMorris Finance B.V. exercises early redemption option for 6.875% Convertible Bonds due 2026, to be redeemed at nominal value plus accrued interest. Bonds may be converted into DocMorris AG shares Shares Convertible Bonds Early Redemption Redeem DocMorris
BRÈVE publiée le 26/01/2026 à 18:35, il y a 3 mois 13 jours DocMorris Repurchases Convertible Bonds Maturing in 2026 Financial Management Convertible Bonds DocMorris AG 2026 Maturity Repurchase Strategy
BRÈVE publiée le 26/01/2026 à 18:35, il y a 3 mois 13 jours DocMorris rachète des obligations convertibles arrivant à échéance en 2026 Obligations Convertibles Gestion Financière DocMorris AG Échéance 2026 Stratégie De Rachat
Publié le 07/05/2026 à 19:15, il y a 1 jour 12 heures 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Publié le 07/05/2026 à 19:15, il y a 1 jour 12 heures Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Publié le 07/05/2026 à 19:06, il y a 1 jour 13 heures Disclosure of Share Capital and Voting Rights as of April 30, 2026
Publié le 07/05/2026 à 19:06, il y a 1 jour 13 heures Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Publié le 07/05/2026 à 19:00, il y a 1 jour 13 heures ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 09/05/2026 à 01:30, il y a 6 heures 40 minutes Star Copper Announces Agreement with Zimtu Capital Corp.
Publié le 09/05/2026 à 00:00, il y a 8 heures 10 minutes Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Publié le 08/05/2026 à 20:38, il y a 11 heures 32 minutes EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Publié le 08/05/2026 à 19:12, il y a 12 heures 58 minutes EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Publié le 08/05/2026 à 19:02, il y a 13 heures 8 minutes Metall Zug – Annual General Meeting of Shareholders approves all proposals